XML 39 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
10. Segment Information (Tables)
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Net sales Information regarding industry segments for the three months ended June 30, 2018 and 2017 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2018
$
217.8

 
$
354.0

 
$
4.1

 
2017
$
179.4

 
$
322.1

 
$
3.2

 
 
 
 
 
 
 
Segment net profit (loss)
2018
$
12.2

 
$
27.8

 
$
—

 
2017
$
(22.9
)
 
$
18.5

 
$
0.2


Information regarding industry segments for the six months ended June 30, 2018 and 2017 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2018
$
415.6

 
$
704.8

 
$
7.0

 
2017
$
353.6

 
$
644.4

 
$
6.7

 
 
 
 
 
 
 
Segment net profit (loss)
2018
$
15.5

 
$
64.4

 
$
—

 
2017
$
(41.7
)
 
$
60.1

 
$
0.4



Prior year amounts have been adjusted (see Note 1 to the condensed consolidated financial statements in regard to ASU 2017-07 for pension and other postretirement benefits).
Reconciliation of segment profit to consolidated income before taxes The following reconciles total segment profit to consolidated income before taxes (in millions):
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2018
 
2017
 
2018
 
2017
Total segment profit (loss)
$
40.0

 
$
(4.2
)
 
$
79.9

 
$
18.8

Foreign currency exchange losses, net
—

 
(2.5
)
 
(1.2
)
 
(4.3
)
Net corporate operating, interest and other expense not allocated to segments
(2.2
)
 
(3.6
)
 
(4.2
)
 
(5.6
)
Change in fair market value of equity securities
286.4

 
—

 
1,102.3

 
—

Other income (expense), net
15.9

 
11.4

 
27.0

 
12.4

Consolidated income before income taxes
$
340.1

 
$
1.1

 
$
1,203.8

 
$
21.3


Prior year amounts have been adjusted (see Note 1 to the condensed consolidated financial statements in regard to ASU 2017-07 for pension and other postretirement benefits).